Search results for "Capacity"

showing 10 items of 999 documents

Combined Effect of Sauna Bathing and Cardiorespiratory Fitness on the Risk of Sudden Cardiac Deaths in Caucasian Men: A Long-term Prospective Cohort …

2018

Both cardiorespiratory fitness (CRF) and frequency of sauna bathing (FSB) are each strongly and independently associated with sudden cardiac death (SCD) risk. However, the combined effect of CRF and FSB on SCD risk has not been previously investigated. We evaluated the joint impact of CRF and FSB on the risk of SCD in the Kuopio Ischemic Heart Disease prospective cohort study of 2291 men aged 42-61 years at recruitment. Objectively measured CRF and self-reported sauna bathing habits were assessed at baseline. CRF was categorized as low and high (median cutoffs) and FSB as low and high (defined as ≤2 and 3-7 sessions/week respectively). Multivariable adjusted hazard ratios (HRs) with confide…

MalePhysical fitness030204 cardiovascular system & hematologySudden cardiac deathCohort Studies0302 clinical medicineMedicineProspective Studiesäkkikuolema030212 general & internal medicineProspective cohort studyFinlandcardiorespiratory fitnessheart diseasesIncidenceHazard ratioAge FactorsVO2 maxta3142Middle Agedfyysinen kuntoCardiovascular Diseasesaerobinen suorituskykyCardiology and Cardiovascular MedicineCohort studyAdultsaunamedicine.medical_specialtysaunominenRisk AssessmentWhite Peoplesudden cardiac deathSteam Bath03 medical and health sciencesInternal medicineHumansAerobic exercisesydäntauditCardiorespiratory fitnessExercisebusiness.industryCardiorespiratory fitnessmedicine.diseasesauna bathingaerobic capacitySudden cardiac deathDeath Sudden Cardiacphysical fitnessSaunabusinessProgress in Cardiovascular Diseases
researchProduct

Direct and indirect effects of Growth Hormone Deficiency (GHD) on lung function in children: A mediation analysis

2018

Background: Studies on pulmonary function tests (PFTs) in Growth Hormone Deficiency (GHD) children are lacking. The aims of this study were: (i) to investigate PFTs in GHD pre-pubertal children with respect to Controls, before starting Growth Hormone Therapy (GHT) (T0); (ii) to evaluate changes of PFTs in GHD vs Controls, after 1-year GHT (T1). Forboth aims the mediation analysis (MA) was applied to evaluate the extent to which the relationship between GHD and PFTs could be ascribed to a height-mediated (indirect) or a GH direct effect. Methods: 47 pre-pubertal GHD children (aged 5–14 years) underwent PFTs at T0 and T1. At T0, 47 healthy children matched for age and sex were enrolled as Contr…

MalePulmonary and Respiratory MedicineAdolescentFunctional Residual CapacityVital CapacityPhysiology030209 endocrinology & metabolismGrowth hormoneAge and sexPulmonary function testingGrowth hormone deficiency03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineForced Expiratory VolumeStatistical analysesmedicineHumansChildDwarfism PituitaryLungChildrenStatistical softwareLung functionCarbon MonoxideHuman Growth HormoneNegotiatingbusiness.industryChildren Growth-hormone-deficiency Lung function tests Mediation analysisTotal Lung CapacityGrowth-hormone-deficiencymedicine.diseaseRespiratory Function TestsResidual VolumeItaly030228 respiratory systemGrowth HormoneLung function testsMediation analysisFemalebusiness
researchProduct

Asthma control in elderly asthmatics. An Italian observational study

2014

SummaryBackgroundThe exponential increase of individuals aged >64 yrs is expected to impact the burden of asthma. We aimed to explore the level of asthma control in elderly subjects, and factors influencing it.MethodsA multicenter observational study was performed on consecutive patients >64 years old with a documented physician-diagnosis of asthma. Sixteen Italian centers were involved in this 6-month project.FindingsA total of 350 patients were enrolled in the study. More than one-third of elderly asthmatic patients, despite receiving GINA step 3–4 antiasthmatic therapy, had an Asthma Control Test score ≤19, with a quarter experiencing at least one severe asthma exacerbation in the previo…

MalePulmonary and Respiratory MedicineChronic ObstructiveChronic bronchitismedicine.medical_specialtyExacerbationVital CapacitySettore MED/10 - Malattie Dell'Apparato Respiratorioelderly patientsPulmonary DiseasePulmonary Disease Chronic ObstructiveFEV1/FVC ratioElderlyForced Expiratory VolumeInternal medicinemedicineHumansAnti-Asthmatic AgentsAsthma control testAsmaAgedAsthmaCOPDAsma; elderly patientsAsthma; Asthma control test; Elderly; Aged; Anti-Asthmatic Agents; Asthma; Female; Forced Expiratory Volume; Humans; Male; Pulmonary Disease Chronic Obstructive; Treatment Outcome; Vital Capacitybusiness.industryOverlap syndromemedicine.diseaseAsthma control test; Elderly; AsthmaAsthmarespiratory tract diseasesTreatment OutcomeSalbutamolPhysical therapyFemaleObservational studybusinessmedicine.drug
researchProduct

High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD

2012

<b><i>Background:</i></b> The literature shows conflicting results when high-resolution computed tomography (HRCT) scores of emphysema were correlated with different indices of airflow obstruction. <b><i>Objectives:</i></b> We correlated HRCT scores of emphysema with different indices of airflow obstruction. <b><i>Methods:</i></b> We performed HRCT of the chest in 59 patients, all smokers or ex-smokers, with stable chronic obstructive pulmonary disease of different severity [GOLD stages I–IV; mean age ± SD 67.8 ± 7.3 years; pack/years 51.0 ± 34.6; percent predicted forced expiratory volume in 1 s (FEV<sub>1</su…

MalePulmonary and Respiratory MedicineEmphysema COPD High-resolution computed tomography Lung structural alterationsVital capacityHigh-resolution computed tomographyPulmonary diseaseLung structural alterationsSeverity of Illness IndexPulmonary Disease Chronic ObstructiveFEV1/FVC ratioSeverity of illnessmedicineHumansCOPDLung volumesLung functionHigh-resolution computed tomographyAgedEmphysemaCOPDmedicine.diagnostic_testbusiness.industryChronic obstructive pulmonary diseaseSmokingrespiratory systemmedicine.diseaseBronchodilator AgentsRespiratory Function Testsrespiratory tract diseasesPulmonary EmphysemaAnesthesiaMultivariate AnalysisFemaleTomography X-Ray ComputedbusinessNuclear medicineChronic obstructive pulmonary disease; Emphysema; High-resolution computed tomography; Lung structural alterations;
researchProduct

Alterations of the beneficial effect of deep inspiration in scleroderma: relationships between lung function and imaging.

2007

<i>Background:</i> It has been postulated that the beneficial effects of deep inspiration are dependent on the magnitude of airway distension by virtue of airway to parenchyma interdependence. <i>Objective:</i> This study was designed to examine whether the changes that occur in pulmonary fibrosis affect the beneficial effect of deep inspiration. <i>Methods:</i> Thirty-one subjects with scleroderma underwent lung volume and diffusion capacity assessment as well as high-resolution computed tomography. To assess the effect of deep inspiration, each subject underwent methacholine provocations in the absence of deep breaths. When the targeted change in lung f…

MalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyPulmonary FibrosisVital CapacityDistensionSettore MED/10 - Malattie Dell'Apparato RespiratorioBronchial Provocation TestsSclerodermaBronchoconstrictor AgentsScleroderma LocalizedForced Expiratory VolumeParenchymamedicineHumansLungMethacholine ChlorideBronchusLungbusiness.industryRespiratory diseaseInterstitial lung diseaseMiddle Agedrespiratory systemmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureInhalationRespiratory Mechanicsconnettive diseases lung inflation imagingFemaleTomography X-Ray ComputedAirwaybusiness
researchProduct

Bronchodilatory Effect of Deep Inspiration Is Absent in Subjects With Mild COPD

2004

Study objectives To investigate whether the bronchodilatory effect of deep inspiration is impaired in subjects with COPD. Methods We measured deep inspiration-induced bronchodilation in 19 patients with COPD and 17 healthy subjects (mean age, 67.8 ± 7.1 years vs 62.5 ± 9.3 years, respectively [± SEM]). Each subject underwent a series of single-dose methacholine provocations to induce at least a 15% reduction in inspiratory vital capacity (IVC). When this was achieved, subjects were asked to perform four consecutive deep inspirations, after which the IVC measurement was repeated and the percentage of bronchodilation by deep inspiration was calculated. Results The percentage of reduction in I…

MalePulmonary and Respiratory MedicineSpirometryAgingVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioCritical Care and Intensive Care MedicineSensitivity and Specificitylung function COPDBronchial Provocation TestsStatistics NonparametricPulmonary Disease Chronic ObstructiveReference ValuesForced Expiratory VolumeBronchodilationmedicineHumansLung volumesMethacholine ChlorideAgedProbabilityAged 80 and overCOPDmedicine.diagnostic_testPulmonary Gas Exchangebusiness.industryMiddle AgedAirway obstructionPrognosismedicine.diseaserespiratory tract diseasesBronchodilatationInhalationSpirometryCase-Control StudiesAnesthesiaRespiratory MechanicsFemaleBronchoconstrictionMethacholinemedicine.symptomLung Volume MeasurementsCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Spirometry Reference Values for Women and Men Aged 65–85 Living in Southern Europe: The Effect of Health Outcomes

2002

<i>Background:</i> Spirometry is more and more frequently used for the diagnosis of respiratory diseases in the elderly people. Unfortunately, reliable predictive values for the spirometric variables in the elderly are lacking. <i>Objectives:</i> Data obtained from 429 subjects participating in the multicenter Italian study SARA on respiratory health in the elderly were analyzed in order to derive reference values for spirometry in the age range of 65–85 years. The second aim of this study was to assess the influence of variables describing many dimensions of the health status on the prediction of spirometric variables in that age range. <i>Methods:</i> S…

MalePulmonary and Respiratory MedicineSpirometryGerontologyHealth StatusVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioHealth outcomesReference ValuesForced Expiratory VolumemedicineHumansMulticenter Studies as TopicElderly peopleReference ValueAgedAged 80 and overmedicine.diagnostic_testbusiness.industrysocial sciencesPredictive valuehumanitiesEuropeSpirometryReference valuesFemalebusinessHumanRespiration
researchProduct

Use of a portable device to record maximum inspiratory flow in relation to dyspnoea in patients with COPD

2011

SummaryForced inspiratory measures have been described to reflect the reduction in dyspnoea upon bronchodilation in severe COPD. Based on this we evaluated the applicability and usefulness of a portable device for the assessment of forced inspiration. In 37 patients with COPD (GOLD II/II/IV n = 16/15/6, mean ± SD FEV1 46.2 ± 15.4%pred) lung function was recorded prior to inhalation of 24 μg formoterol and 30 min later. Assessments comprised spirometry including forced inspiration, body plethysmography, maximum inspiratory flow (InCheck, Clement Clarke), and changes in dyspnoea via visual analogue scale (VAS). The sequence was repeated on a second day to assess reproducibility. Bronchodilati…

MalePulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyPortable deviceVisual analogue scalePeak inspiratory flowPulmonary Disease Chronic ObstructiveForced inspirationInternal medicineDyspnoeaBronchodilationCOPDHumansMedicinePlethysmographPeak flow meterMonitoring Physiologicmeasurement_unitAnalysis of VarianceCOPDmedicine.diagnostic_testbusiness.industrymedicine.diseaserespiratory tract diseasesBronchodilatationDyspneaSpirometrymeasurement_unit.measuring_instrumentPhysical therapyCardiologyBronchodilationFemaleFormoterolbusinessInspiratory Capacitymedicine.drugRespiratory Medicine
researchProduct

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with mod…

2015

Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium for the treatment of COPD. The QUANTIFY study compared QVA149 with a free-dose bronchodilator combination of tiotropium plus formoterol (TIO+FOR) in improving health-related quality of life (HRQoL) of patients with COPD. Methods This multicentre, blinded, triple-dummy, parallel-group, non-inferiority study randomised patients aged ≥40 years with moderate-to-severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% to <80% predicted) to QVA149 110/50 µg o.d. or TIO 18 µg o…

MalePulmonary and Respiratory MedicineVital capacitymedicine.drug_classChronic Obstructive Pulmonary DiseaseVital CapacityScopolamine DerivativesQuinolonesCOPD PharmacologyDrug Administration SchedulePulmonary Disease Chronic ObstructiveFEV1/FVC ratioDouble-Blind MethodQuality of lifeForced Expiratory VolumeFormoterol FumarateBronchodilatorHumansMedicine1506Tiotropium BromideAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryMiddle Agedmedicine.diseaseGlycopyrrolateBronchodilator Agentsrespiratory tract diseasesDrug CombinationsTreatment OutcomeEthanolaminesBronchodilator AgentsAnesthesiaIndansQuality of LifeIndacaterolFemaleFormoterolbusinessmedicine.drugThorax
researchProduct

Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease

2008

SummaryBackgroundEpidemiologic studies have demonstrated that elderly patients with fixed airflow obstruction can be affected by asthma or chronic obstructive pulmonary disease (COPD).MethodsWe studied 49 consecutive elderly outpatients, presenting fixed airflow obstruction, by clinical history (smoking), pulmonary function tests, blood gas analysis, and induced sputum.ResultsThe age was not different in patients with COPD (n=28) and asthma (n=21) (70.2±3.9 years vs. 69.6±3.7 years), also the degree of fixed airflow obstruction was similar (FEV1: 58.3±1.5% vs. 59.0±1.4% of predicted). Patients with asthma had significantly more eosinophils in peripheral blood (0.43±0.05×10−3μL vs. 0.27±0.1×…

MalePulmonary and Respiratory MedicineVital capacitymedicine.medical_specialtySettore MED/09 - Medicina Internaasthma chronic obstructive pulmonary disease.NeutrophilsVital Capacitychronic obstructive pulmonary disease.GastroenterologyPulmonary function testingPulmonary Disease Chronic ObstructiveFEV1/FVC ratioElderlyDLCOForced Expiratory VolumeInternal medicinemedicineHumanselderly patients; fixed airflow obstruction; asthma; chronic obstructive pulmonary disease.AgedAsthmaCOPDEosinophil cationic proteinbusiness.industryChronic obstructive pulmonary diseasefixed airflow obstructionRespiratory diseaseSputumasthmamedicine.diseaseRespiratory Function Testselderly patientrespiratory tract diseasesSurgeryEosinophilsFemalebusinessRespiratory Medicine
researchProduct